241 related articles for article (PubMed ID: 28290443)
1. Inhibition of hepatic lipogenesis enhances liver tumorigenesis by increasing antioxidant defence and promoting cell survival.
Nelson ME; Lahiri S; Chow JD; Byrne FL; Hargett SR; Breen DS; Olzomer EM; Wu LE; Cooney GJ; Turner N; James DE; Slack-Davis JK; Lackner C; Caldwell SH; Hoehn KL
Nat Commun; 2017 Mar; 8():14689. PubMed ID: 28290443
[TBL] [Abstract][Full Text] [Related]
2. Metabolome Analyses Uncovered a Novel Inhibitory Effect of Acyclic Retinoid on Aberrant Lipogenesis in a Mouse Diethylnitrosamine-Induced Hepatic Tumorigenesis Model.
Qin XY; Tatsukawa H; Hitomi K; Shirakami Y; Ishibashi N; Shimizu M; Moriwaki H; Kojima S
Cancer Prev Res (Phila); 2016 Mar; 9(3):205-14. PubMed ID: 26744170
[TBL] [Abstract][Full Text] [Related]
3. PGC1α promotes tumor growth by inducing gene expression programs supporting lipogenesis.
Bhalla K; Hwang BJ; Dewi RE; Ou L; Twaddel W; Fang HB; Vafai SB; Vazquez F; Puigserver P; Boros L; Girnun GD
Cancer Res; 2011 Nov; 71(21):6888-98. PubMed ID: 21914785
[TBL] [Abstract][Full Text] [Related]
4. β-Arrestin1 enhances hepatocellular carcinogenesis through inflammation-mediated Akt signalling.
Yang Y; Guo Y; Tan S; Ke B; Tao J; Liu H; Jiang J; Chen J; Chen G; Wu B
Nat Commun; 2015 Jun; 6():7369. PubMed ID: 26077142
[TBL] [Abstract][Full Text] [Related]
5. Sex hormone-binding globulin suppresses NAFLD-triggered hepatocarcinogenesis after menopause.
Lee SR; Lee YH; Yang H; Lee HW; Lee GS; An BS; Jeung EB; Park BK; Hong EJ
Carcinogenesis; 2019 Aug; 40(8):1031-1041. PubMed ID: 31168625
[TBL] [Abstract][Full Text] [Related]
6. Persistent mTORC1 activation via Depdc5 deletion results in spontaneous hepatocellular carcinoma but does not exacerbate carcinogen- and high-fat diet-induced hepatic carcinogenesis in mice.
Xu L; Yang C; Wang J; Li Z; Huang R; Ma H; Ma J; Wang Q; Xiong X
Biochem Biophys Res Commun; 2021 Nov; 578():142-149. PubMed ID: 34562654
[TBL] [Abstract][Full Text] [Related]
7. TLR4 Deficiency Protects against Hepatic Fibrosis and Diethylnitrosamine-Induced Pre-Carcinogenic Liver Injury in Fibrotic Liver.
Weber SN; Bohner A; Dapito DH; Schwabe RF; Lammert F
PLoS One; 2016; 11(7):e0158819. PubMed ID: 27391331
[TBL] [Abstract][Full Text] [Related]
8. Acetyl-coenzyme A carboxylase alpha promotion of glucose-mediated fatty acid synthesis enhances survival of hepatocellular carcinoma in mice and patients.
Wang MD; Wu H; Fu GB; Zhang HL; Zhou X; Tang L; Dong LW; Qin CJ; Huang S; Zhao LH; Zeng M; Wu MC; Yan HX; Wang HY
Hepatology; 2016 Apr; 63(4):1272-86. PubMed ID: 26698170
[TBL] [Abstract][Full Text] [Related]
9. Salicylate activates AMPK and synergizes with metformin to reduce the survival of prostate and lung cancer cells ex vivo through inhibition of de novo lipogenesis.
O'Brien AJ; Villani LA; Broadfield LA; Houde VP; Galic S; Blandino G; Kemp BE; Tsakiridis T; Muti P; Steinberg GR
Biochem J; 2015 Jul; 469(2):177-87. PubMed ID: 25940306
[TBL] [Abstract][Full Text] [Related]
10. Fructose-1,6-Bisphosphate Aldolase B Depletion Promotes Hepatocellular Carcinogenesis Through Activating Insulin Receptor Signaling and Lipogenesis.
Liu G; Wang N; Zhang C; Li M; He X; Yin C; Tu Q; Shen X; Zhang L; Lv J; Wang Y; Jiang H; Chen S; Li N; Tao Y; Yin H
Hepatology; 2021 Dec; 74(6):3037-3055. PubMed ID: 34292642
[TBL] [Abstract][Full Text] [Related]
11. Extracellular ATP and Purinergic P2Y
Schulien I; Hockenjos B; van Marck V; Ayata CK; Follo M; Thimme R; Hasselblatt P
Cancer Res; 2020 Feb; 80(4):699-708. PubMed ID: 31822494
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Acetyl-CoA Carboxylase by Phosphorylation or the Inhibitor ND-654 Suppresses Lipogenesis and Hepatocellular Carcinoma.
Lally JSV; Ghoshal S; DePeralta DK; Moaven O; Wei L; Masia R; Erstad DJ; Fujiwara N; Leong V; Houde VP; Anagnostopoulos AE; Wang A; Broadfield LA; Ford RJ; Foster RA; Bates J; Sun H; Wang T; Liu H; Ray AS; Saha AK; Greenwood J; Bhat S; Harriman G; Miao W; Rocnik JL; Westlin WF; Muti P; Tsakiridis T; Harwood HJ; Kapeller R; Hoshida Y; Tanabe KK; Steinberg GR; Fuchs BC
Cell Metab; 2019 Jan; 29(1):174-182.e5. PubMed ID: 30244972
[TBL] [Abstract][Full Text] [Related]
13. Anticarcinogenic activity of nanoencapsulated quercetin in combating diethylnitrosamine-induced hepatocarcinoma in rats.
Ghosh A; Ghosh D; Sarkar S; Mandal AK; Thakur Choudhury S; Das N
Eur J Cancer Prev; 2012 Jan; 21(1):32-41. PubMed ID: 21968689
[TBL] [Abstract][Full Text] [Related]
14. Identification of the Potential Metabolic Pathways Involved in the Hepatic Tumorigenesis of Rat Diethylnitrosamine-Induced Hepatocellular Carcinoma via
Chen M; Lu S; Zheng H; Xu M; Song J; Yang W; Weng Q; Zheng L; Fan X; Cheng X; Gao H; Ji J
Biomed Res Int; 2019; 2019():9367082. PubMed ID: 30719453
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of androgen/AR signaling inhibits diethylnitrosamine (DEN) induced tumour initiation and remodels liver immune cell networks.
Helms TH; Mullins RD; Thomas-Ahner JM; Kulp SK; Campbell MJ; Lucas F; Schmidt N; LeMoine DM; Getaneh S; Xie Z; Phelps MA; Clinton SK; Coss CC
Sci Rep; 2021 Feb; 11(1):3646. PubMed ID: 33574348
[TBL] [Abstract][Full Text] [Related]
16. Chronic administration of diethylnitrosamine to induce hepatocarcinogenesis and to evaluate its synergistic effect with other hepatotoxins in mice.
Fuentes-Hernández S; Alarcón-Sánchez BR; Guerrero-Escalera D; Montes-Aparicio AV; Castro-Gil MP; Idelfonso-García OG; Rosas-Madrigal S; Aparicio-Bautista DI; Pérez-Hernández JL; Reyes-Gordillo K; Lakshman MR; Vásquez-Garzón VR; Baltiérrez-Hoyos R; López-González ML; Sierra-Santoyo A; Villa-Treviño S; Pérez-Carreón JI; Arellanes-Robledo J
Toxicol Appl Pharmacol; 2019 Sep; 378():114611. PubMed ID: 31176654
[TBL] [Abstract][Full Text] [Related]
17. USP22 regulates lipidome accumulation by stabilizing PPARγ in hepatocellular carcinoma.
Ning Z; Guo X; Liu X; Lu C; Wang A; Wang X; Wang W; Chen H; Qin W; Liu X; Zhou L; Ma C; Du J; Lin Z; Luo H; Otkur W; Qi H; Chen D; Xia T; Liu J; Tan G; Xu G; Piao HL
Nat Commun; 2022 Apr; 13(1):2187. PubMed ID: 35449157
[TBL] [Abstract][Full Text] [Related]
18. [Molecular and metabolic changes in human clear cell liver foci].
Ribback S; Calvisi DF; Cigliano A; Rausch J; Heidecke CD; Birth M; Dombrowski F
Pathologe; 2015 Nov; 36 Suppl 2():210-5. PubMed ID: 26483250
[TBL] [Abstract][Full Text] [Related]
19. Cell expression patterns of CD147 in N-diethylnitrosamine/phenobarbital-induced mouse hepatocellular carcinoma.
Lu M; Wu J; He F; Wang XL; Li C; Chen ZN; Bian H
J Mol Histol; 2015 Feb; 46(1):79-91. PubMed ID: 25447507
[TBL] [Abstract][Full Text] [Related]
20. Chronic administration of recombinant IL-6 upregulates lipogenic enzyme expression and aggravates high-fat-diet-induced steatosis in IL-6-deficient mice.
Vida M; Gavito AL; Pavón FJ; Bautista D; Serrano A; Suarez J; Arrabal S; Decara J; Romero-Cuevas M; Rodríguez de Fonseca F; Baixeras E
Dis Model Mech; 2015 Jul; 8(7):721-31. PubMed ID: 26035386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
